These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 29931113

  • 1. Live Vaccination Generates Both Disease Tolerance and Host Resistance During Chronic Pulmonary Infection With Highly Virulent Francisella tularensis SchuS4.
    Soucy AM, Hurteau GJ, Metzger DW.
    J Infect Dis; 2018 Oct 20; 218(11):1802-1812. PubMed ID: 29931113
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
    Tian D, Uda A, Park ES, Hotta A, Fujita O, Yamada A, Hirayama K, Hotta K, Koyama Y, Azaki M, Morikawa S.
    Microbiol Immunol; 2018 Jan 20; 62(1):24-33. PubMed ID: 29171073
    [Abstract] [Full Text] [Related]

  • 3. An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain.
    Bakshi CS, Malik M, Mahawar M, Kirimanjeswara GS, Hazlett KR, Palmer LE, Furie MB, Singh R, Melendez JA, Sellati TJ, Metzger DW.
    Vaccine; 2008 Sep 26; 26(41):5276-88. PubMed ID: 18692537
    [Abstract] [Full Text] [Related]

  • 4. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.
    Wayne Conlan J, Shen H, Kuolee R, Zhao X, Chen W.
    Vaccine; 2005 Mar 31; 23(19):2477-85. PubMed ID: 15752834
    [Abstract] [Full Text] [Related]

  • 5. Low dose vaccination with attenuated Francisella tularensis strain SchuS4 mutants protects against tularemia independent of the route of vaccination.
    Rockx-Brouwer D, Chong A, Wehrly TD, Child R, Crane DD, Celli J, Bosio CM.
    PLoS One; 2012 Mar 31; 7(5):e37752. PubMed ID: 22662210
    [Abstract] [Full Text] [Related]

  • 6. Long lived protection against pneumonic tularemia is correlated with cellular immunity in peripheral, not pulmonary, organs.
    Anderson RV, Crane DD, Bosio CM.
    Vaccine; 2010 Sep 14; 28(40):6562-72. PubMed ID: 20688042
    [Abstract] [Full Text] [Related]

  • 7. Protection of vaccinated mice against pneumonic tularemia is associated with an early memory sentinel-response in the lung.
    Bar-On L, Cohen H, Elia U, Rotem S, Bercovich-Kinori A, Bar-Haim E, Chitlaru T, Cohen O.
    Vaccine; 2017 Dec 15; 35(50):7001-7009. PubMed ID: 29102170
    [Abstract] [Full Text] [Related]

  • 8. Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background.
    Chen W, Shen H, Webb A, KuoLee R, Conlan JW.
    Vaccine; 2003 Sep 08; 21(25-26):3690-700. PubMed ID: 12922099
    [Abstract] [Full Text] [Related]

  • 9. BALB/c mice, but not C57BL/6 mice immunized with a ΔclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: association of protection with post-vaccination and post-challenge immune responses.
    Twine S, Shen H, Harris G, Chen W, Sjostedt A, Ryden P, Conlan W.
    Vaccine; 2012 May 21; 30(24):3634-45. PubMed ID: 22484348
    [Abstract] [Full Text] [Related]

  • 10. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.
    Baron SD, Singh R, Metzger DW.
    Infect Immun; 2007 May 21; 75(5):2152-62. PubMed ID: 17296747
    [Abstract] [Full Text] [Related]

  • 11. Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A.
    Wu TH, Hutt JA, Garrison KA, Berliba LS, Zhou Y, Lyons CR.
    Infect Immun; 2005 May 21; 73(5):2644-54. PubMed ID: 15845466
    [Abstract] [Full Text] [Related]

  • 12. Vaccination with an attenuated strain of Francisella novicida prevents T-cell depletion and protects mice infected with the wild-type strain from severe sepsis.
    Sharma J, Li Q, Mishra BB, Georges MJ, Teale JM.
    Infect Immun; 2009 Oct 21; 77(10):4314-26. PubMed ID: 19635830
    [Abstract] [Full Text] [Related]

  • 13. Mouse model of oral infection with virulent type A Francisella tularensis.
    KuoLee R, Zhao X, Austin J, Harris G, Conlan JW, Chen W.
    Infect Immun; 2007 Apr 21; 75(4):1651-60. PubMed ID: 17242058
    [Abstract] [Full Text] [Related]

  • 14. Deletion of IglH in virulent Francisella tularensis subsp. holarctica FSC200 strain results in attenuation and provides protection against the challenge with the parental strain.
    Straskova A, Cerveny L, Spidlova P, Dankova V, Belcic D, Santic M, Stulik J.
    Microbes Infect; 2012 Feb 21; 14(2):177-87. PubMed ID: 21930232
    [Abstract] [Full Text] [Related]

  • 15. Successful protection against tularemia in C57BL/6 mice is correlated with expansion of Francisella tularensis-specific effector T cells.
    Griffin AJ, Crane DD, Wehrly TD, Bosio CM.
    Clin Vaccine Immunol; 2015 Jan 21; 22(1):119-28. PubMed ID: 25410207
    [Abstract] [Full Text] [Related]

  • 16. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R, Harris G, Conlan JW, Chen W.
    Vaccine; 2007 May 10; 25(19):3781-91. PubMed ID: 17346863
    [Abstract] [Full Text] [Related]

  • 17. Tularemia vaccines: recent developments and remaining hurdles.
    Conlan JW.
    Future Microbiol; 2011 Apr 10; 6(4):391-405. PubMed ID: 21526941
    [Abstract] [Full Text] [Related]

  • 18. Discordant results obtained with Francisella tularensis during in vitro and in vivo immunological studies are attributable to compromised bacterial structural integrity.
    Singh A, Rahman T, Malik M, Hickey AJ, Leifer CA, Hazlett KR, Sellati TJ.
    PLoS One; 2013 Apr 10; 8(3):e58513. PubMed ID: 23554897
    [Abstract] [Full Text] [Related]

  • 19. Susceptibility of various mouse strains to systemically- or aerosol-initiated tularemia by virulent type A Francisella tularensis before and after immunization with the attenuated live vaccine strain of the pathogen.
    Shen H, Chen W, Conlan JW.
    Vaccine; 2004 Jun 02; 22(17-18):2116-21. PubMed ID: 15149767
    [Abstract] [Full Text] [Related]

  • 20. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain.
    Pechous R, Celli J, Penoske R, Hayes SF, Frank DW, Zahrt TC.
    Infect Immun; 2006 Aug 02; 74(8):4452-61. PubMed ID: 16861631
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.